Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 6
1951 3
1952 5
1953 4
1954 5
1956 1
1958 1
1959 3
1960 3
1961 5
1962 2
1963 3
1964 6
1966 1
1967 3
1968 4
1969 2
1970 3
1971 2
1976 2
1978 2
1979 1
1980 3
1981 2
1983 3
1984 5
1985 5
1986 4
1988 3
1989 5
1990 3
1991 5
1992 10
1993 2
1994 6
1995 8
1996 8
1997 8
1998 6
1999 7
2000 5
2001 12
2002 9
2003 25
2004 19
2005 23
2006 23
2007 33
2008 31
2009 52
2010 47
2011 54
2012 38
2013 42
2014 55
2015 78
2016 68
2017 64
2018 58
2019 73
2020 76
2021 99
2022 89
2023 78
2024 70
2025 98

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,314 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
Foà R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, Canichella M, Viero P, Ferrara F, Lunghi M, Fabbiano F, Bonifacio M, Fracchiolla N, Di Bartolomeo P, Mancino A, De Propris MS, Vignetti M, Guarini A, Rambaldi A, Chiaretti S; GIMEMA Investigators. Foà R, et al. Among authors: vitale a. N Engl J Med. 2020 Oct 22;383(17):1613-1623. doi: 10.1056/NEJMoa2016272. N Engl J Med. 2020. PMID: 33085860 Clinical Trial.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR, Lai Q, Casadei-Gardini A, Celsa C, Galati G, Gambato M, Crocetti L, Renzulli M, Giannini EG, Farinati F, Trevisani F, Cillo U; HCC Special Interest Group of the Italian Association for the Study of the Liver. Vitale A, et al. Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9. Lancet Oncol. 2023. PMID: 37414020 Review.
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
Merlino L, D'Ovidio G, Matys V, Piccioni MG, Porpora MG, Senatori R, Viscardi MF, Vitale A, Della Rocca C, On Behalf Of Policlinico Umberto I Collaborators. Merlino L, et al. Among authors: vitale a. Pharmaceuticals (Basel). 2023 Apr 6;16(4):550. doi: 10.3390/ph16040550. Pharmaceuticals (Basel). 2023. PMID: 37111307 Free PMC article. Review.
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis.
Crane H, Eslick GD, Gofton C, Shaikh A, Cholankeril G, Cheah M, Zhong JH, Svegliati-Baroni G, Vitale A, Kim BK, Ahn SH, Kim MN, Strasser SI, George J. Crane H, et al. Among authors: vitale a. Clin Mol Hepatol. 2024 Jul;30(3):436-448. doi: 10.3350/cmh.2024.0109. Epub 2024 Apr 16. Clin Mol Hepatol. 2024. PMID: 38623613 Free PMC article.
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.
Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S, DeWolf WC, Lamm DL, Kates M, Hyndman ME, Kamat AM, Bivalacqua TJ, Nepple KG, O'Donnell MA. Steinberg RL, et al. Among authors: vitale a. J Urol. 2020 May;203(5):902-909. doi: 10.1097/JU.0000000000000688. Epub 2019 Dec 10. J Urol. 2020. PMID: 31821066
Reply.
Conrady CD, Hu K, Shakoor A, Larochelle M, Sassalos T, Elner SG, Jayasundera T, Vitale AT. Conrady CD, et al. Among authors: vitale at. Ophthalmol Retina. 2022 May;6(5):437-438. doi: 10.1016/j.oret.2021.12.009. Ophthalmol Retina. 2022. PMID: 35525579 No abstract available.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Innovazione applicata alla gestione dei pazienti in transizione di cura: l’evoluzione dell’Area di continuità assistenziale tra ospedale e territorio.
Carcieri C, Scalpello S, Bosio A, Zanelli R, Fazzina G, Torrengo S, Bo A, Savant Levet P, Armano P, Vitale A, Azzolina MC, Dall'Acqua MG, Gasco A. Carcieri C, et al. Among authors: vitale a. Recenti Prog Med. 2023 Sep;114(9):557. doi: 10.1701/4088.40814. Recenti Prog Med. 2023. PMID: 37530021 Italian. No abstract available.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R. Bassan R, et al. Among authors: vitale a. Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596. Blood Adv. 2023. PMID: 37276451 Free PMC article.
1,314 results